45 research outputs found

    MECANISMOS FISIOLÓGICOS E FISIOPATOLÓGICOS DETERMINANTES DA ATIVIDADE VASOMOTORA SIMPÁTICA

    Get PDF
    The sympathetic vasomotor activity is one of determinants of blood pressure (BP). Understanding the mechanisms involved in the control of the cardiovascular system is important in physiological and pathophysiological condition. The principal sympathetic premotor brain nuclei are confined in the paraventricular nucleus of hypothalamus (PVN) and in the rostralventrolateral medulla (RVLM). In different patophysiological condition, there is an increase in the sympathetic vasomotor tone, in part due to an increase in the activity of the PVN and RVLM neurons. In this brief review, we discussed the major mechanisms of sympathetic activation in different experimental models: 1) renovascular hypertension, 2) renoprival hypertension, 3) cardiac failure, 4) hypertension induced by nitric oxide blockade, 5) obesity and 6) gender differences. The actions of different mediators in the PVN and in the RVLM acting in long term, can change the level of sympathetic nerve activity and blood pressure and therefore, contributing for the progression of cardiovascular disease.A atividade vasomotora simpática é um dos determinantes da pressão arterial (PA). Estabelecer quais são os mecanismos geradores dessa atividade é importante para o entendimento de como o sistema cardiovascular opera, tanto em situações fisiológicas como fisiopatológicas. Os principais grupos pré-motores do simpático estão confinados no núcleo paraventricular do hipotálamo (PVN) e região rostoventrolateral bulbar (RVLM). Em diversas situações fisiopatológicas há aumento na atividade vasomotora simpática, em parte conseqüente a maior atividade dos neurônios do PVN e RVLM. Nesta breve revisão, foram discutidos os principais mecanismos de ativação simpática em diferentes modelos experimentais: 1) hipertensão renovascular, 2) hipertensão por baixa massa renal, 3) insuficiência cardíaca, 4) hipertensão por bloqueio do óxido nítrico, 5) obesidade e 6) dimorfismo sexual. As ações de diferentes mediadores sobre o PVN e RVLM podem em longo prazo determinar novos patamares de atividade simpática, modificando os níveis tensionais e dessa forma, contribuir para a progressão da doença cardiovascular

    Kininolytic Activity of Human Amniotic Fluid

    Full text link

    TIME COURSE of INSULIN, CORTICOSTERONE and METABOLIC CHANGES CAUSED BY LESION of the VENTROMEDIAL HYPOTHALAMUS in the RAT

    No full text
    ESCOLA PAULISTA MED,DEPT PHYSIOL,DIV NEUROPHYSIOL & ENDOCRINE PHYSIOL,BR-04023 São Paulo,SP,BRAZILESCOLA PAULISTA MED,DEPT PHYSIOL,DIV NEUROPHYSIOL & ENDOCRINE PHYSIOL,BR-04023 São Paulo,SP,BRAZILWeb of Scienc

    NEURAL MECHANISMS INVOLVED in the RECOVERY FROM INSULIN HYPOGLYCEMIA in DOGS

    No full text
    NIMH,CEREBRAL METAB LAB,BETHESDA,MD 20205UNIV São Paulo,INST BIOMED SCI,DEPT PHYSIOL & PHARMACOL,BR-05508 São Paulo,SP,BRAZILEscola Paulista de MedicinaWeb of Scienc

    Neonatal monosodium glutamate treatment alters rat intestinal muscle reactivity to some agonists

    No full text
    The following study is an investigation of the changes in the contractile reactivity of visceral muscles in response to agonists and alterations in metabolic parameters after neonatal rat treatment with monosodium-L-glutamate. This treatment markedly sensitizes ileum and colon preparations to adenosine-5'-triphosphate (ATP) stimulation and also increases the colon activity to acetylcholine (p < 0.05). Response to bradykinin remained unchanged, while ileum activity to angiotensin II was characterized by a reduction in the maximal tension (E-max) and an increase in the EC50 (p < 0.05) value. the responses of nonintestinal muscle preparations from monosodium-glutamate-treated rats to both ATP and bradykinin did not show a significant difference when compared to the controls. This treatment diminished food intake, feces excretion and increased plasma insulin, nonesterified fatty acids and triglyceride concentrations(p < 0.001). These results suggest that the changes in intestinal muscle activity, in response to agonists, can be due to metabolic alterations as well as the monosodium glutamate action on enteric neurons and/or smooth muscle receptors. (C) 1999 Elsevier Science B.V. All rights reserved.Universidade Federal de São Paulo, Escola Paulista Med, Dept Biophys, BR-04023062 São Paulo, BrazilUniversidade Federal de São Paulo, Escola Paulista Med, Dept Physiol, BR-04023062 São Paulo, BrazilUniversidade Federal de São Paulo, Escola Paulista Med, Dept Biophys, BR-04023062 São Paulo, BrazilUniversidade Federal de São Paulo, Escola Paulista Med, Dept Physiol, BR-04023062 São Paulo, BrazilWeb of Scienc
    corecore